The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAtlantic Lithium Regulatory News (ALL)

Share Price Information for Atlantic Lithium (ALL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 21.70
Bid: 21.70
Ask: 21.85
Change: -0.10 (-0.46%)
Spread: 0.15 (0.691%)
Open: 21.00
High: 22.10
Low: 21.00
Prev. Close: 21.80
ALL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Issue of Equity - Exercise of ESOP Options

22 Aug 2023 07:00

RNS Number : 0542K
Atlantic Lithium Limited
22 August 2023
 

 

 

22 August 2023

Directors DealingsIssue of Equity - Exercise of ESOP Options

The Board of Atlantic Lithium Limited (AIM: ALL, ASX: A11, OTCQX: ALLIF, "Atlantic Lithium" or the "Company"), the African-focused lithium exploration and development company targeting to deliver Ghana's first lithium mine, wishes to advise the allotment and issue of 3,000,000 ordinary shares of no par value each in the Company ("Ordinary Shares") at a price of 30 pence per share as a result of the exercise of unlisted ESOP options which were granted on 18 August 2021 to Len Kolff and held in the name of a person closely associated ("PCA") of Mr Kolff.

A PCA of Len Kolff, Head of Business Development & Chief Geologist, has acquired 3,000,000 new Ordinary Shares at a price of 30p each as a result of the exercise of ESOP options, for a total consideration of £900,000.

Application will be made for the total 3,000,000 Ordinary Shares to be admitted to trading on AIM ("Admission"). Admission is expected to take place on or around 30 August 2023.

Following Admission, the beneficial shareholdings of the Directors will be as follows:

Director / PDMR Role

Current number of Ordinary Shares held

% of Share Capital

Neil Herbert

7,638,892

1.25

Amanda Harsas

4,200,000

0.68

Len Kolff

6,180,852

1.01

Patrick Brindle

108,000

0.02

Keith Muller

-

-

Kieran Daly

-

-

Christelle van der Merwe

-

-

Total

18,127,744

2.96

 

On Admission of the 3,000,000 Ordinary Shares to trading, the issued share capital of the Company will comprise 612,241,660 Ordinary Shares. When calculating voting rights, shareholders should use this figure as the denominator for the calculations by which they determine if they are required to notify their interest in, or change in their interest in, the share capital of the Company.

 

 

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM:

 

ISSUE OF ORDINARY SHARES

 

1.

Details of the person discharging managerial responsibilities/person closely associated

a)

Name:

Melisa Kolff van Oosterwijk

2.

Reason for the notification

a)

Position/status:

PCA of Lennard Kolff van Oosterwijk, Head of Business Development & Chief Geologist

b)

Initial notification/Amendment:

Initial notification 

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name:

Atlantic Lithium Limited 

b)

LEI:

213800H1JY3J7BB6BN06

4.

1. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted.

a)

Description of the financial instrument, type of instrument:

Identification code:

Ordinary Shares of no par value

ISIN: AU0000237554

b)

Nature of the transaction:

Exercise of ESOP Options

 

c)

Price(s) and volume(s):

 Price(s)

Volume(s)

30p

 

3,000,000

 

 

d)

Aggregated information:

 

Single transaction as in 4 c) above

 Price(s)

Volume(s)

30p

 

3,000,000

 

 

 

e)

Date of the transaction:

22 August 2023

f)

Place of the transaction:

Outside of a trading venue

Certain information contained in this announcement would have been deemed inside information for the purposes of Article 7 of Regulation (EU) No 596/2014 until the release of this announcement.

 

For any further information, please contact:

Atlantic Lithium Limited

Neil Herbert (Executive Chairman)

Amanda Harsas (Finance Director and Company Secretary)

www.atlanticlithium.com.au

IR@atlanticlithium.com.au

Tel: +61 2 8072 0640

 

SP Angel Corporate Finance LLP

Nominated Adviser

Jeff Keating

Charlie Bouverat

Tel: +44 (0)20 3470 0470

Yellow Jersey PR Limited

Charles Goodwin

Bessie Elliot atlantic@yellowjerseypr.com

Tel: +44 (0)20 3004 9512

 

Canaccord Genuity Limited

Company Broker

Raj Khatri / James Asensio

Harry Rees

Tel: +44 (0) 20 7523 4500

 

Notes to Editors:

 

About Atlantic Lithium

www.atlanticlithium.com.au

Atlantic Lithium is an AIM and ASX-listed lithium company advancing a portfolio of lithium projects in Ghana and Côte d'Ivoire through to production.

The Company's flagship project, the Ewoyaa Project in Ghana, is a significant lithium spodumene pegmatite discovery on track to become Ghana's first lithium-producing mine. The Company signed a funding agreement with Piedmont Lithium Inc. towards the development of the Ewoyaa Project. Atlantic Lithium is currently advancing the Ewoyaa Project through feasibility studies and intends to be producing a spodumene concentrate via simple gravity only process flowsheet.

Atlantic Lithium holds 560km2 and 774km2 of tenure across Ghana and Côte d'Ivoire respectively, comprising significantly under-explored, highly prospective licences.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IOENKBBNQBKKPFB
Date   Source Headline
10th Jun 20087:00 amRNSAward of Contract
2nd Jun 20087:00 amRNSAward of Contracts
27th May 20089:34 amRNSDirector/PDMR Shareholding
22nd May 20087:00 amRNSAward of Contract
6th May 20087:02 amRNSAward of Directors' Options
2nd May 20087:00 amRNSHolding(s) in Company
7th Apr 20087:01 amRNSAcquisition
4th Apr 20087:01 amRNSTrading Statement
26th Mar 20088:00 amRNSAward of Contract
17th Mar 20087:00 amRNSAward of Contract
10th Mar 20087:00 amRNSAward of Contract
4th Mar 20087:00 amRNSAward of Contract
28th Feb 20089:01 amRNSExercise of Share Options
26th Feb 20087:00 amRNSAward of Contract
21st Feb 20087:00 amRNSAward of Contract
6th Feb 20087:01 amRNSInterim Results
4th Feb 20087:01 amRNSAward of Contract
31st Jan 20087:00 amRNSAward of Contract
22nd Jan 20087:00 amRNSAward of Contract
18th Jan 20087:01 amRNSAward of Contract
17th Jan 20087:00 amRNSHolding(s) in Company
15th Jan 200812:06 pmRNSHolding(s) in Company
4th Jan 20089:38 amRNSTotal Voting Rights
4th Jan 20087:00 amRNSAward of Contract
4th Jan 20087:00 amRNSAward of Contract
3rd Jan 20088:46 amRNSAward of Contract
20th Dec 20077:01 amRNSAGM Statement
12th Dec 200711:13 amRNSHolding(s) in Company
11th Dec 20077:00 amRNSCorrection: Holdings in Co.
10th Dec 20074:43 pmRNSHolding(s) in Company
3rd Dec 200711:30 amRNSDirector/PDMR Shareholding
29th Nov 20077:01 amRNSCirc re. contract extension
21st Nov 20077:01 amRNSDirector/PDMR Shareholding
20th Nov 20077:01 amRNSChange of Adviser
8th Nov 200710:08 amRNSHolding(s) in Company
7th Nov 20071:34 pmRNSAward of Contract
5th Nov 20073:00 pmRNSDirector/PDMR Shareholding
18th Oct 200712:08 pmRNSRe Contract
27th Sep 20075:18 pmRNSHolding(s) in Company
27th Sep 20073:30 pmRNSAward of contract
20th Sep 20073:15 pmRNSAward of Contract
19th Sep 200711:31 amRNSHolding(s) in Company
19th Sep 20079:02 amRNSDirector/PDMR Shareholding
5th Sep 200710:25 amRNSHolding(s) in Company
23rd Aug 20071:47 pmRNSAward of Contract
17th Aug 200711:59 amRNSHolding(s) in Company
6th Aug 20071:00 pmRNSAward of Contract
31st Jul 20077:01 amRNSDirector/PDMR Shareholding
30th Jul 200712:29 pmRNSCompany Website
30th Jul 20077:00 amRNSFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.